Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI

Abroad (travel likely)Recruiting

Conditions

Glioma · Brain Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

France Institut de cancérologie Strasbourg Europe, Strasbourg, France
Contact: Study coordinator (Manon VOEGELIN) · promotion-rc@icans.eu
Contact: Principal Investigator (Izzie-Jacques NAMER, MD, PhD)
Caroline BUND, MD, PhD (Sub-investigator)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Brain Tumor · Brain Metastases · Brain Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Glioblastoma (GBM) · Newly Diagnosed Glioblastoma · GBM

Abroad (travel likely)RecruitingPHASE2

Springdale, United States · Los Angeles, United States

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

IDH1 wt Allele · Recurrent Anaplastic Astrocytoma · Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Houston, United States